CRBU Market Cap History



Below is a table of the CRBU market cap history going back to 7/23/2021:

Date CRBU Market Cap
7/23/2021835.73M
8/31/20211.63B
11/5/20211.35B
3/17/2022575.70M
5/4/2022506.28M
8/1/2022487.94M
11/3/2022575.24M
5/4/2023270.00M
8/3/2023603.87M
11/2/2023327.20M
3/5/2024662.91M

Also see: CRBU Shares Outstanding History
and CRBU YTD Return
CRBU Historical Market Cap:
-8.47% CAGR
CRBU Historical Market Cap: +-8.47% CAGR

Mouse over chart for data details
7/23/20218/31/202111/5/20213/17/20225/4/20228/1/202211/3/20225/4/20238/3/202311/2/20233/5/2024
Caribou Biosciences is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats genome-editing biopharmaceutical company focused on developing therapies for patients with devastating diseases. Co.'s CB-010 is a clinical-stage allogeneic anti-CD19 chimeric antigen receptor (CAR)-T (CAR-T) cell therapy with programmed cell death protein 1 removed from the CAR-T cell surface by a genome-edited knockout of the PDCDI gene. Co.'s CB-011 is an allogeneic CAR-T cell therapy that is an anti-B cell maturation antigen CAR-T cell therapy incorporating an immune cloaking approach. Co.'s CB-012 is an allogeneic CAR-T cell therapy targeting C-type lectin-like molecule-1. We show 11 historical shares outstanding datapoints in our CRBU shares outstanding history coverage, used to compute CRBU market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CRBU market cap history over the course of time is important for investors interested in comparing CRBU's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CRBU versus a peer is one thing; comparing CRBU market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CRBU can fluctuate over the course of history. With this page we aim to empower investors researching CRBU by allowing them to research the CRBU market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CRBU Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Caribou Biosciences (CRBU) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CRDF Market Cap History
CRGX Market Cap History
CRH Market Cap History
CRIS Market Cap History
CRL Market Cap History
CRMD Market Cap History
CRNX Market Cap History
CRTX Market Cap History
CRVL Market Cap History
CRVO Market Cap History
More Healthcare companies »

 

CRBU Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.